PortfoliosLab logoPortfoliosLab logo
NOVO-B.CO vs. SU.PA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NOVO-B.CO vs. SU.PA - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in Novo Nordisk A/S (NOVO-B.CO) and Schneider Electric S.E. (SU.PA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

NOVO-B.CO is traded in DKK, while SU.PA is traded in EUR. To make them comparable, the SU.PA values have been converted to DKK using the latest available exchange rates.

Returns By Period

In the year-to-date period, NOVO-B.CO achieves a -14.51% return, which is significantly lower than SU.PA's 16.93% return. Over the past 10 years, NOVO-B.CO has underperformed SU.PA with an annualized return of 15.87%, while SU.PA has yielded a comparatively higher 20.02% annualized return.


NOVO-B.CO

1D
-1.18%
1M
-7.41%
YTD
-14.51%
6M
-7.00%
1Y
-42.63%
3Y*
2.27%
5Y*
19.11%
10Y*
15.87%

SU.PA

1D
0.00%
1M
0.71%
YTD
16.93%
6M
15.61%
1Y
20.86%
3Y*
20.17%
5Y*
17.90%
10Y*
20.02%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NOVO-B.CO vs. SU.PA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NOVO-B.CO
Novo Nordisk A/S
-14.51%-46.40%-9.59%205.34%31.49%79.08%15.29%36.17%-6.15%39.57%
SU.PA
Schneider Electric S.E.
16.93%-0.60%34.57%42.33%-22.55%48.67%32.83%58.60%-13.14%10.44%

Correlation

The correlation between NOVO-B.CO and SU.PA is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Sep 3, 2007

0.25

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NOVO-B.CO vs. SU.PA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NOVO-B.CO
NOVO-B.CO Risk / Return Rank: 1313
Overall Rank
NOVO-B.CO Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
NOVO-B.CO Sortino Ratio Rank: 1313
Sortino Ratio Rank
NOVO-B.CO Omega Ratio Rank: 1212
Omega Ratio Rank
NOVO-B.CO Calmar Ratio Rank: 1212
Calmar Ratio Rank
NOVO-B.CO Martin Ratio Rank: 1717
Martin Ratio Rank

SU.PA
SU.PA Risk / Return Rank: 6363
Overall Rank
SU.PA Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
SU.PA Sortino Ratio Rank: 6060
Sortino Ratio Rank
SU.PA Omega Ratio Rank: 5858
Omega Ratio Rank
SU.PA Calmar Ratio Rank: 6767
Calmar Ratio Rank
SU.PA Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NOVO-B.CO vs. SU.PA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and Schneider Electric S.E. (SU.PA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NOVO-B.COSU.PADifference
Sharpe ratioReturn per unit of total volatility

-1.48

Sortino ratioReturn per unit of downside risk

-2.12

Omega ratioGain probability vs. loss probability

0.87

1.14

-0.27

Calmar ratioReturn relative to maximum drawdown

-0.79

1.23

-2.01

Martin ratioReturn relative to average drawdown

-1.16

3.01

-4.18

NOVO-B.CO vs. SU.PA - Sharpe Ratio Comparison

The current NOVO-B.CO Sharpe Ratio is -0.79, which is lower than the SU.PA Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of NOVO-B.CO and SU.PA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NOVO-B.COSU.PADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.79

0.68

-1.48

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.33

0.60

-0.27

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.36

0.72

-0.36

Sharpe Ratio (All Time)

Calculated using the full available price history

0.78

0.46

+0.32

Drawdowns

NOVO-B.CO vs. SU.PA - Drawdown Comparison

The maximum NOVO-B.CO drawdown since its inception was -76.75%, which is greater than SU.PA's maximum drawdown of -55.99%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and SU.PA.


Loading charts...

Drawdown Indicators


NOVO-B.COSU.PADifference

Max Drawdown

Largest peak-to-trough decline

-76.75%

-55.99%

-20.76%

Max Drawdown (1Y)

Largest decline over 1 year

-54.94%

-17.76%

-37.18%

Max Drawdown (3Y)

Largest decline over 3 years

-76.75%

-31.28%

-45.47%

Max Drawdown (5Y)

Largest decline over 5 years

-76.75%

-35.97%

-40.78%

Max Drawdown (10Y)

Largest decline over 10 years

-76.75%

-35.97%

-40.78%

Current Drawdown

Current decline from peak

-72.07%

-5.88%

-66.19%

Average Drawdown

Average peak-to-trough decline

-11.25%

-11.08%

-0.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

36.82%

7.23%

+29.59%

Volatility

NOVO-B.CO vs. SU.PA - Volatility Comparison

Novo Nordisk A/S (NOVO-B.CO) and Schneider Electric S.E. (SU.PA) have volatilities of 10.59% and 10.26%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NOVO-B.COSU.PADifference

Volatility (1M)

Calculated over the trailing 1-month period

10.59%

10.26%

+0.33%

Volatility (6M)

Calculated over the trailing 6-month period

39.29%

24.38%

+14.91%

Volatility (1Y)

Calculated over the trailing 1-year period

54.59%

31.93%

+22.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

58.54%

29.22%

+29.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

45.06%

27.49%

+17.57%

Dividends

NOVO-B.CO vs. SU.PA - Dividend Comparison

NOVO-B.CO's dividend yield for the trailing twelve months is around 4.35%, more than SU.PA's 1.55% yield.


PositionTTM20252024202320222021202020192018201720162015
NOVO-B.CO
Novo Nordisk A/S
4.35%3.58%1.59%1.01%2.38%2.54%4.03%4.22%5.27%4.54%7.38%2.50%
SU.PA
Schneider Electric S.E.
1.55%1.66%1.45%1.73%2.22%1.51%2.16%2.57%3.68%2.88%3.03%2.59%

Financials

NOVO-B.CO vs. SU.PA - Financials Comparison

This section allows you to compare key financial metrics between Novo Nordisk A/S and Schneider Electric S.E.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. NOVO-B.CO values in DKK, SU.PA values in EUR

Frequently Asked Questions


NOVO-B.CO and SU.PA have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for NOVO-B.CO and SU.PA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer